{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:32:50Z","timestamp":1775817170485,"version":"3.50.1"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177476","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T13:26:54Z","timestamp":1494595614000},"page":"e0177476","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost\u2013benefit analysis"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7017-096X","authenticated-orcid":false,"given":"Thomas G.","family":"Poder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihane","family":"Erraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucien P.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouam\u00e9","family":"Koffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"ref1","first-page":"254","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"G. G. Stefanini","year":"2013"},{"key":"ref2","first-page":"465","article-title":"Du stent coronaire en m\u00e9tal au stent biod\u00e9gradable","volume":"23","author":"P. Bokov","year":"2011"},{"key":"ref3","first-page":"303","article-title":"Coronary stents: 30 years of medical progress","volume":"30","author":"J. Silvain","year":"2014"},{"key":"ref4","first-page":"1393","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"T. Palmerini","year":"2012"},{"key":"ref5","first-page":"e1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D. Moher","year":"2009"},{"key":"ref6","first-page":"1087","article-title":"Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials","volume":"81","author":"D.-F. Geng","year":"2013"},{"key":"ref7","first-page":"1617","article-title":"4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting","volume":"63","author":"M. Taniwaki","year":"2014"},{"key":"ref8","first-page":"e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"S. Bangalore","year":"2012"},{"key":"ref9","first-page":"2873","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"S. Bangalore","year":"2012"},{"key":"ref10","first-page":"378","article-title":"Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials","volume":"6","author":"S. Bangalore","year":"2013"},{"key":"ref11","first-page":"496","article-title":"Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis","volume":"62","author":"T. Palmerini","year":"2013"},{"key":"ref12","first-page":"299","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"T. Palmerini","year":"2014"},{"key":"ref13","first-page":"2496","article-title":"Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis","volume":"65","author":"T. Palmerini","year":"2015"},{"key":"ref14","first-page":"g6427","article-title":"Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis","volume":"349","author":"M. Valgimigli","year":"2014"},{"key":"ref15","first-page":"529","article-title":"Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarction","volume":"102","author":"L. Wang","year":"2014"},{"key":"ref16","first-page":"2344","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"D. E. Cutlip","year":"2007"},{"key":"ref17","first-page":"1393","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"J. V. Tu","year":"2007"},{"key":"ref18","first-page":"391","article-title":"Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials","volume":"11","author":"M. Taniwaki","year":"2015"},{"key":"ref19","first-page":"57","article-title":"Health economic evaluation of the use of drug-eluting stents : First results from the Drug-Eluting Stent Registry (DES.de)","volume":"38","author":"S. N. Willich","year":"2013"},{"key":"ref20","unstructured":"U\u00c9TMIS McGill. Drug Eluting Stents. What should be the indications for their use at the MUHC. U\u00c9TMIS McGill. Rapport 55 29 (2011). at &lt;<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.mcgill.ca\/tau\/fr\/publications\/2011\" xlink:type=\"simple\">http:\/\/www.mcgill.ca\/tau\/fr\/publications\/2011<\/ext-link>&gt;"},{"key":"ref21","first-page":"977","article-title":"Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction","volume":"33","author":"B. Kalesan","year":"2012"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:35:36Z","timestamp":1540035336000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177476"}},"subtitle":[],"editor":[{"given":"Katriina","family":"Aalto-Setala","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177476","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}